Opus Genetics (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited ...
DecisionDx-Melanoma demonstrates robust clinical utility and validated performance, supported by high-quality (SORT A) ...
In a 60-day study, daily consumption appeared to nudge gene activity tied to blood pressure, insulin signaling, and overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback